Skip to content
DataLookout
Menu

ADHD clinical trials

Get alerts when ADHD trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05

What changed in the last 30 days

23 trials changed in the last 30 days: 0 stopped, 10 with notable changes, 13 with minor changes only.

  1. Minor: CBG · Cannabigerol on Attention-Deficit/Hyperactivity Disorder Trial completed University of Arkansas, FayettevillePhase 2 NCT06115603
  2. Minor: ACU-ADHD · Acupuncture for ADHD: Acupoint Data Mining, Clinical Effectiveness, and Interviews to Explore Treatment Outcomes Primary completion pushed from Oct 15, 2026 to Dec 15, 2026 The Third Affiliated Hospital of Beijing University of Chinese MedicineNot applicable NCT06860763
  3. Notable: VREALFUN-ADHD · Virtual Reality in Rehabilitation of Executive Functions · Attention Deficit Hyperactivity Disorder Primary completion pushed from Dec 31, 2025 to Dec 31, 2027 Merja NikulaNot applicable NCT06123741
  4. Minor: Spark BATIR · New Method to Improve Informed Consent in Prison Research Trial completed Stéphanie BaggioNot applicable NCT06378281
  5. Notable: Psychophysiological Responses to Six Single-Session Self-Regulation Interventions in a Female · ADHD and Stabilized Bipolar Disorder Primary and study completion pushed from Oct 30, 2026 to Apr 30, 2027 Poznan University of Physical EducationNot applicable NCT07437833
  6. Notable: Lemborexant vs Clonidine vs Sedatives · Insomnia in Chronic Pain Patients Enrollment reopened Salem Anaesthesia Pain ClinicNot specified NCT05618002
  7. Minor: TEAM-DS · Treatment of ADHD · Down Syndrome Trial completed Children's Hospital Medical Center, CincinnatiPhase 4 NCT04219280
  8. Notable: QAIAx · SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074, 526, 64/063, 557, 64/105, 164, 63/903, 181, 63/729, 428, 64/125, 360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War) Start date pushed from Sep 1, 2026 to Oct 1, 2026 Veterans Recovery Network Inc.Not applicable NCT07661823
  9. Minor: ALKS 7290 Compared With Placebo · Attention Deficit Hyperactivity Disorder (ALKS 7290-201) Trial sites expanded: 19 → 28 locations Alkermes, Inc.Phase 2 NCT07755410
  10. Notable: Loving Habits: A Feasibility Study of a Support Program for Building New Parent-child Behavioral Habits Primary and study completion dates pushed to Jun 2027 Okinawa Institute of Science and Technology Graduate UniversityNot applicable NCT07291453
  11. Minor: TNS-PAE · Trigeminal Nerve Stimulation · Prenatal Alcohol Exposure Primary and study completion pushed from Sep 30, 2026 to Dec 29, 2026 University of California, Los AngelesNot applicable NCT06847165
  12. Minor: PEAR · Parent-Educator Action Response Trial status changed: Enrolling by Invitation → Active, Not Recruiting Ann & Robert H Lurie Children's Hospital of ChicagoNot applicable NCT07203014
  13. Notable: Pai.ACT: AI-Driven ACT Chatbot for Mental Health Triage and Service Evaluation Primary completion pushed from Feb 28, 2026 to Jan 31, 2027 Chinese University of Hong KongNot applicable NCT06808555
  14. Minor: Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers Trial completed National Institute of Mental Health (NIMH)Not specified NCT00001246
  15. Minor: Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) Trial completed Duke UniversityNot applicable NCT07089745
  16. Minor: Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2) Trial sites expanded: 23 → 30 locations Axsome Therapeutics, Inc.Phase 3 NCT07717879
  17. Minor: Solriamfetol in Children and · ADHD Trial sites expanded: 3 → 7 locations Axsome Therapeutics, Inc.Phase 3 NCT07773883
  18. Minor: Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3) Trial sites expanded: 24 → 28 locations Axsome Therapeutics, Inc.Phase 3 NCT07717892
  19. Notable: VRAM · Virtual Reality Attention Management Primary and study completion dates pushed to Sep 2, 2027 University of California, DavisNot applicable NCT03221244
  20. Notable: RAISE · Rural Autistic Individuals - Supporting Expression Primary and study completion dates pushed to Dec 2027 Montana State UniversityNot applicable NCT07054866
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-11-03 NCT07913997 Cognitive-Motor Training With the DextEgg in Children With ADHD Manuela Pastore-Wapp new
2026-10-27 NCT07898592 Single Session Support for Parents of Children With Neurodevelopmental Disabilities… Boston University Charles River Campus new
2026-09-28 NCT07845292 Methodology of Super-Early Training of Developer Engineers and Leading Analysts With a… Pisareva Citadel Group LLC new
2026-09-15 NCT07821060 Developing Microbiome and Dietary Strategies Based on Chrono-nutrition for Targeting ADHD Spanish National Research Council new
2026-09-10 NCT07812948 Personalising ADHD Medication Treatment for Children and Young People University of Southampton new
2026-09-10 NCT07812987 Rapid Entrainment and Signal-guided Neuromodulation for Behavioral Health Tactical Mind Research Coalition, Inc. new
2026-08-28 NCT07793045 Binaural Beats Stimulation for Adults With Attention-Deficit/Hyperactivity Disorder California State University, San Bernardino new
2026-08-10 NCT07755410 A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult… Alkermes new Phase 2

Active trials by phase

Early Phase 1
2
Phase 1
3
Phase 1/2
4
Phase 2
7
Phase 2/3
3
Phase 3
12
Phase 4
22
Not charted: 232 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Get alerts when ADHD trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free